Scissortail Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
+2,855
New +$195K 0.04% 104
2025
Q4
Sell
-2,855
Closed -$209K 110
2025
Q3
$209K Buy
+2,855
New +$190K 0.05% 112
2022
Q3
Sell
-3,255
Closed -$131K 108
2022
Q2
$131K Buy
+3,255
New +$141K 0.05% 112
2022
Q1
Sell
-3,255
Closed -$131K 109
2021
Q4
$131K Buy
+3,255
New +$122K 0.05% 112

Other funds holding HALO

Scissortail Wealth Management's HALO Position: Q2 2026 in Review

Scissortail Wealth Management opened a new position in Halozyme (HALO) in Q2 2026: 2,855 shares worth $223K. The stake represents 0.04% of the portfolio and ranks #104 among its holdings. This is a return to the name: Scissortail Wealth Management previously reported a position in HALO as recently as Q3 2025.

Scissortail Wealth Management first reported a position in HALO in Q4 2021 and has held it in 4 quarters since. 342 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Scissortail Wealth Management held 2,855 shares of Halozyme worth $223K as of Q2 2026.
  • Halozyme was a new Scissortail Wealth Management position in Q2 2026.
  • Halozyme made up 0.04% of Scissortail Wealth Management's portfolio in Q2 2026, its #104 holding.
  • Scissortail Wealth Management first reported a position in Halozyme in Q4 2021 and has held it in 4 quarters since.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Scissortail Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.